No connection

Search Results

Analysis Neutral

Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know

Apr 08, 2026 11:50 UTC

Key PointsA director of Arcutis Biotherapeutics reported selling 10,000 shares for a total transaction value of $239,000 on April 1, 2026..

  • April 08, 2026 — 07:50 am EDT Written byJonathan PoncianoforThe Motley Fool-> A director of Arcutis Biotherapeutics reported selling 10,000 shares for a total transaction value of $239,000 on April 1, 2026
  • This sale represented 20
  • 10% of Howard G

April 08, 2026 — 07:50 am EDT Written byJonathan PoncianoforThe Motley Fool-> A director of Arcutis Biotherapeutics reported selling 10,000 shares for a total transaction value of $239,000 on April 1, 2026. This sale represented 20.10% of Howard G. Welgus's direct common stock holdings, reducing his position from 49,744 to 39,744 shares. The transaction involved only direct ownership; no indirect entities or derivative securities were implicated. Director Howard G. Welgus reported the sale of 10,000 shares ofArcutis Biotherapeutics(NASDAQ:ARQT)on April 1, 2026, according to aSEC Form 4 filing.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile